Using conventional ELISA assays, we set out to determine if our patients with pemphigus had Abs against three of the dominant non-DSG autoantigens, nAChR, M3AChR, and TPO, and if those Ab levels correlated with the levels of anti-DSG Abs, clinical disease activity, and response to therapy. This evidence concerns the gene CHRM3 and pemphigus.